EPISODE · Aug 15, 2024 · 40 MIN
NECROTEK with Jonathan Maberry
from Quills and Chills · host Rick Clifton
In this episode of Quills & Chills, join me as I sit down with acclaimed author Jonathan Mayberry to discuss his latest book, Necrotech. With a career spanning roles as a New York Times bestseller, multiple award-winner, and editor of Weird Tales magazine, Mayberry brings a wealth of experience to the table. The conversation delves into his unique journey into writing, the thematic elements of human resilience and ingenuity in Necrotech, and the profound inspirations behind his Lovecraftian cosmic horror novel. Mayberry also teases upcoming sequels and shares insights into his creative process and character development. Follow Jonathan: jonathanmaberry.com IG | Threads: @JonathanMaberry twitter | x: @JonathanMaberry FB: jonathan.maberry.5 Follow Quills & Chills on social: IG: @quillsandchills Bluesky: @quillsandchills.bsky.social TWITTER: @QuillsAndChills YOUTUBE: @quillsandchillspodcast
What this episode covers
In this episode of Quills & Chills, join me as I sit down with acclaimed author Jonathan Mayberry to discuss his latest book, Necrotech. With a career spanning roles as a New York Times bestseller, multiple award-winner, and editor of Weird Tales magazine, Mayberry brings a wealth of experience to the table. The conversation delves into his unique journey into writing, the thematic elements of human resilience and ingenuity in Necrotech, and the profound inspirations behind his Lovecraftian cosmic horror novel. Mayberry also teases upcoming sequels and shares insights into his creative process and character development. Follow Jonathan: jonathanmaberry.com IG | Threads: @JonathanMaberry twitter | x: @JonathanMaberry FB: jonathan.maberry.5 Follow Quills & Chills on social: IG: @quillsandchills Bluesky: @quillsandchills.bsky.social TWITTER: @QuillsAndChills YOUTUBE: @quillsandchillspodcast
NOW PLAYING
NECROTEK with Jonathan Maberry
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m